Use of Metformin and Survival in Patients with Hepatocellular Carcinoma (HCC) Undergoing Liver Directed Therapy: Analysis of a Nationwide Cancer Registry.
Kumar MukherjeeMohammad ElsayedEshani ChoksiMohammed F LoyaRichard DuszakMehmet AkceBill S MajdalanyZachary L BercuMircea CristescuNima KokabiPublished in: Cardiovascular and interventional radiology (2023)
Metformin use is associated with improved survival in HCC patients undergoing TACE and ablation.